pyrimidine has been researched along with Bile Duct Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HJ; Choi, JH; Eum, JB; Jang, JW; Kim, HJ; Kim, MH; Lee, JB; Lee, JL; Lee, SK; Lee, SS; Park, DH; Park, SE; Seo, DW | 1 |
| Bang, YJ; Chie, EK; Ha, SW; Han, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY | 1 |
1 trial(s) available for pyrimidine and Bile Duct Neoplasms
| Article | Year |
|---|---|
Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bile Duct Neoplasms; Cholangiocarcinoma; Combined Modality Therapy; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Photochemotherapy; Prospective Studies; Pyrimidines; Quality of Life; Retreatment; Survival Analysis; Tegafur; United States | 2014 |
1 other study(ies) available for pyrimidine and Bile Duct Neoplasms
| Article | Year |
|---|---|
Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Liver Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Prognosis; Pyrimidines; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate; Treatment Failure; Tumor Burden | 2012 |